Author: vivani

Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent’s Ongoing Orion Clinical Study

vivani | April 4, 2023

 Read More  

Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

vivani | March 31, 2023

 Read More  

Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division

vivani | March 21, 2023

 Read More  

Vivani Medical Reports Third Quarter 2022 Results and Provides Business Updates

vivani | November 14, 2022

 Read More  

Vivani Medical to Present at the ThinkEquity Investor Conference

vivani | November 14, 2022

 Read More  

Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)

vivani | August 31, 2022

 Read More  

Second Sight Medical Products Announces Successful Completion of its Merger with Nano Precision Medical and its Name Change to Vivani Medical, Inc.

vivani | August 30, 2022

 Read More  

Second Sight Medical Products, Inc. Announces Shareholder Approval for Proposed Merger with Nano Precision Medical, Inc. and other Results of 2022 Annual Meeting

vivani | July 29, 2022

 Read More  

Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study

vivani | July 18, 2022

 Read More  

Nano Precision Medical Co-Founder and CEO Discusses Proposed Second Sight Merger in Interview to Air on Bloomberg U.S. on the RedChip Money Report®

vivani | April 14, 2022

 Read More